ES on precision oncology PARP Drugs Help Some Breast Cancer Patients, But They’re No Magic BulletApril 30, 2018ForbesWhy All Cancer Patients Should Have Access To Genomic TestingMarch 6, 2018Forbes7 Key Cancer Trends For 2018December 31, 2017ForbesA New PARP Drug For Breast Cancer? I’m Thrilled!December 18, 2017ForbesActually, Many New Cancer Drugs May Be Helpful And Worth TryingOctober 24, 2017ForbesA Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure ItSeptember 11, 2017ForbesPrecision Oncology Drug Shows Power Of Cancer GenomicsJune 9, 2017ForbesIn Bold Move, FDA Approves Cancer Drug For Any Advanced Tumor With Genetic ChangesMay 23, 2017ForbesBayer’s Stivarga Shows Slim Progress Against Liver CancerApril 27, 2017ForbesWhich Patients Will Be Helped By Immune Cancer Drugs? This Test May TellApril 12, 2017ForbesA PARP Inhibitor Keeps Some Cancers In Check For YearsMarch 16, 2017ForbesEncouraging Results For Ribociclib In Advanced Breast CancerOctober 9, 2016ForbesA Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal CancerJune 20, 2016ForbesThe Emerging Value Of Personalized Phase 1 Clinical Trials In OncologyJune 2, 2016ForbesCould New Lung Cancer Meds Keep Walter White From Breaking Bad?March 31, 2016featured,ForbesBlood Test Offers An Amazing View Of Metastatic Prostate Cancer CellsFebruary 1, 2016ForbesFive Key Issues For The Future Of Cancer ITNovember 30, 2015ForbesCompanion Diagnostics? For Cancer Care, We Need Better OnesNovember 19, 2015ForbesPrecision Medicine Is A Needed Goal That Will Benefit Cancer PatientsNovember 9, 2015ForbesPrecision Medicine Will (Eventually) Lower Cancer Care CostsOctober 1, 2015ForbesIn A First, Kidney Cancer Drug Extends SurvivalSeptember 26, 2015ForbesLynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of TumorsMay 4, 2015ForbesThinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In CancerMarch 31, 2015ForbesNovel Drug Expands Treatment Options For Women With Metastatic Breast CancerFebruary 4, 2015ForbesFor Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted TherapyDecember 5, 2014ForbesPerjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors?September 28, 2014ForbesThe (Unmet) Potential Value of Cancer Genome TestingSeptember 24, 2014ForbesWith So Many Terrific New Drugs For Chronic Lymphocytic Leukemia, Why Worry?August 28, 2014ForbesAmbitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung CancerJune 23, 2014ForbesA Chip against Cancer: Microfluidics Spots Circulating Tumor CellsApril 1, 2009Scientific American
